SCHEMBL186291

SCHEMBL186291

O=S(O)OCCCOS(=O)O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2835119 0.93 CA1 (0.31) CA1CA2
Ethylene Glycol SCHEMBL21809034 0.91
SCHEMBL27716803 0.87
SCHEMBL273257 0.86 CA1 (0.36) CA1CA2
SCHEMBL2229678 0.85
SCHEMBL1713922 0.83
SCHEMBL21809029 0.83
SCHEMBL778734 0.83
Sulfurous Acid SCHEMBL197348 0.83 CA1 (0.43) CA1CA2
SCHEMBL21809059 0.81 GAA (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 568 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250385315-A1 ELECTROLYTE FOR USE IN SECONDARY LITHIUM BATTERIES WITH NICKEL-RICH CATHODE MATERIALS BATTELLE MEMORIAL INSTITUTE (US) 2025-12-18 US claimed
US-20250277257-A1 HYBRIDIZATION COMPOSITIONS AND METHODS DAKO DENMARK APS (DK) 2025-09-04 US claimed
EP-4597643-A1 SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK AND ELECTRIC DEVICE Contemporary Amperex Technology (Hong Kong) Limited (HK) 2025-08-06 EP claimed
US-20250246693-A1 SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL DEVICE CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2025-07-31 US claimed
US-12209276-B2 Hybridization compositions and methods AGILENT TECHNOLOGIES, INC. (US) 2025-01-28 US claimed
US-20240318052-A1 METHOD OF UNDERWATER BONDING HENKEL AG & CO KGAA (DE) 2024-09-26 US claimed
WO-2024196936-A2 LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME SILA NANOTECHNOLOGIES, INC. (US) 2024-09-26 WO claimed
US-20240322244-A1 LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME SILA NANOTECHNOLOGIES, INC. 2024-09-26 US claimed
CN-118355041-A Method for underwater bonding 汉高股份有限及两合公司 2024-07-16 CN claimed
WO-2024130554-A1 SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK AND ELECTRIC DEVICE 宁德时代新能源科技股份有限公司 2024-06-27 WO claimed
US-20110281263-A1 Compositions and Methods for Detection of Chromosomal Aberrations with Novel Hybridization Buffers DAKO DENMARK APS (DK) 2011-11-17 US claimed
US-20110229975-A1 Hybridization Compositions and Methods DAKO DENMARK APS (DK) 2011-09-22 US claimed
WO-2011067678-A2 COMPOSITIONS AND METHODS FOR PERFORMING HYBRIDIZATIONS WITH NO DENATURATION MATTHIESEN STEEN H (DK) 2011-06-09 WO claimed
EP-2285979-A1 HYBRIDIZATION COMPOSITIONS AND METHODS Dako Denmark A/S (DK) 2011-02-23 EP claimed
EP-2285982-A2 COMPOSITIONS AND METHODS FOR DETECTION OF CHROMOSOMAL ABERRATIONS WITH NOVEL HYBRIDIZATION BUFFERS Dako Denmark A/S (DK) 2011-02-23 EP claimed
WO-2010097656-A1 COMPOSITIONS AND METHODS FOR PERFORMING A STRINGENT WASH STEP IN HYBRIDIZATION APPLICATIONS DAKO DENMARK A/S (DK) 2010-09-02 WO claimed
WO-2010097655-A1 COMPOSITIONS AND METHODS FOR RNA HYBRIDIZATION APPLICATIONS DAKO DENMARK A/S (DK) 2010-09-02 WO claimed
WO-2010097707-A1 COMPOSITIONS AND METHODS FOR PERFORMING HYBRIDIZATIONS WITH SEPARATE DENATURATION OF THE SAMPLE AND PROBE DAKO DENMARK A/S (DK) 2010-09-02 WO claimed
WO-2009147537-A2 COMPOSITIONS AND METHODS FOR DETECTION OF CHROMOSOMAL ABERRATIONS WITH NOVEL HYBRIDIZATION BUFFERS DAKO DENMARK A/S (DK) 2009-12-10 WO claimed
WO-2009144581-A1 HYBRIDIZATION COMPOSITIONS AND METHODS DAKO DENMARK A/S (DK) 2009-12-03 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110229975-A1 Hybridization Compositions and Methods POLRMT, POLL, POLH CA1 352/4885CA2 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.